State Police Services

Update on human variations web-based electronic application form implementation on product lifecycle management portal, Online, from 6 November 2023, 13:30 (CET) to 6 November 2023, 15:00 (CET)

Retrieved on: 
Monday, December 18, 2023

This is a first step towards making the form-filling and submission-handling process more efficient.

Key Points: 
  • This is a first step towards making the form-filling and submission-handling process more efficient.
  • The web-based Variations eAF for Human medicinal Centrally Authorised Products (CAPs) was released on 4 November 2022.
  • Following the Product Management Service (PMS) data release, the form will support all types of EU variation procedures, CAPs and Nationally Authorised Products (NAPs).
  • The event aims at providing interested parties with comprehensive insights into the implementation progress, challenges, and future prospects of the web-based eAF within the PLM Portal.

COP28 UAE Presidency announces priorities to drive water up the climate agenda

Retrieved on: 
Thursday, August 24, 2023

The COP28 Presidency also announced a partnership with the co-hosts of the UN 2023 Water Conference, Netherlands and Tajikistan, who will serve as COP28 Water Champions to help lead the Agenda.

Key Points: 
  • The COP28 Presidency also announced a partnership with the co-hosts of the UN 2023 Water Conference, Netherlands and Tajikistan, who will serve as COP28 Water Champions to help lead the Agenda.
  • STOCKHOLM, Aug. 24, 2023 /PRNewswire/ -- The COP28 UAE Presidency has launched its Water Agenda during World Water Week in Stockholm, which took place from August 20 to 24.
  • Furthermore, the COP28 Presidency announced a partnership with the Netherlands and Tajikistan to serve as COP28 Water Champions.
  • This partnership unites the COP28 Presidency, Tajikistan, and the Netherlands to deliver water policy, technology, and financing results at COP28.

COP28 UAE and UNFCCC urge G20 nations to show leadership on climate change mitigation and adaptation

Retrieved on: 
Friday, July 28, 2023

Those at the frontline of climate change need our support now, not in 5 years' time.

Key Points: 
  • Those at the frontline of climate change need our support now, not in 5 years' time.
  • The G20 must show that it can deliver for the most climate vulnerable, including the least developed countries and small island developing states.
  • Dr. Sultan Al-Jaber, COP28 President-Designate and Simon Stiell, Executive Secretary of the United Nations Framework Convention on Climate Change (UNFCCC), have called upon G20 nations to take a greater leadership role in climate change mitigation and adaptation.
  • As mandated by the Paris Climate Agreement, COP28 UAE will deliver the first ever Global Stocktake – a comprehensive evaluation of progress against climate goals.

COP28 Calls on Governments to ensure Food Systems and Agriculture are central to Climate Action Efforts

Retrieved on: 
Monday, July 24, 2023

The COP28 Food Systems and Agriculture Agenda has four pillars, covering national leadership, non-state actors, scaling up innovation, and finance.

Key Points: 
  • The COP28 Food Systems and Agriculture Agenda has four pillars, covering national leadership, non-state actors, scaling up innovation, and finance.
  • The COP28 Presidency calls on governments to sign a Leaders Declaration on Food Systems, Agriculture and Climate Action and integrate food systems and agriculture into national climate agendas.
  • The Presidency, represented by Her Excellency Mariam Almheiri, UAE Minister for Climate Change and Environment and COP28 Food Systems Lead, called on governments to demonstrate leadership by signing the first-ever Leaders Declaration on Food Systems, Agriculture and Climate Action during the Food Systems Summit in Rome.
  • In addition, the COP28 Presidency will call upon a diverse group of stakeholders in the food and agriculture sector to accelerate existing initiatives across food systems, agriculture, and climate action.

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

Retrieved on: 
Wednesday, June 21, 2023

SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that the company is presenting several posters collectively highlighting data from its liver disease programs at the European Association for the Study of the Liver (EASL) Congress 2023, taking place in Vienna, Austria, June 21 – 24, 2023.

Key Points: 
  • Notably, the Company’s late breaking poster (LBP-18) highlights promising emerging data from its ongoing Phase 1b study evaluating the oral capsid assembly modulator (CAM-E), ALG-000184.
  • Importantly, ALG-000184 continues to demonstrate a favorable safety and pharmacokinetic (PK) profile over these extended dosing durations.
  • “We are excited to present emerging clinical data from our CHB portfolio of drug candidates at EASL,” said Lawrence Blatt, Ph.D., MBA, Chairman & CEO of Aligos Therapeutics.
  • “The data presented highlights the progress we have made advancing new targeted therapies for multiple liver diseases.

Aligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

Retrieved on: 
Wednesday, June 7, 2023

“These presentations highlight the progress we have made advancing new potentially best-in-class compounds,” said Lawrence Blatt, Ph.D., MBA, Chairman & CEO of Aligos Therapeutics.

Key Points: 
  • “These presentations highlight the progress we have made advancing new potentially best-in-class compounds,” said Lawrence Blatt, Ph.D., MBA, Chairman & CEO of Aligos Therapeutics.
  • The presentations will be available on the Scientific Presentations and Conferences page on Aligos’ corporate website following the meeting.
  • Additionally, the pharmacodynamic response of HBsAg reduction and durability correlated with total siRNA and RISC-bound siRNA in mouse liver.
  • There is the potential for a significantly improved therapeutic window by precision targeting of only the DNA transactivating region of the multifunctional β-catenin protein.

THE NDC PARTNERSHIP SUPPORTS COUNTRIES TO LEVERAGE OPPORTUNITIES ACROSS THE WATER-CLIMATE NEXUS

Retrieved on: 
Friday, March 24, 2023

First, we need to change the focus of water governance and apply a Water Nexus approach.

Key Points: 
  • First, we need to change the focus of water governance and apply a Water Nexus approach.
  • The Partnership supports countries to deliver on climate action, decreasing their climate vulnerability related to water and increasing public and private investments in Water-Nexus opportunities.
  • Specifically, the Partnership will provide guidance to countries on opportunities to strengthen NDC implementation through a water-climate nexus approach.
  • "With initial support from the Netherlands, the NDC Partnership will help countries leverage opportunities across the Water Nexus.

THE NDC PARTNERSHIP SUPPORTS COUNTRIES TO LEVERAGE OPPORTUNITIES ACROSS THE WATER-CLIMATE NEXUS

Retrieved on: 
Friday, March 24, 2023

First, we need to change the focus of water governance and apply a Water Nexus approach.

Key Points: 
  • First, we need to change the focus of water governance and apply a Water Nexus approach.
  • The Partnership supports countries to deliver on climate action, decreasing their climate vulnerability related to water and increasing public and private investments in Water-Nexus opportunities.
  • Specifically, the Partnership will provide guidance to countries on opportunities to strengthen NDC implementation through a water-climate nexus approach.
  • "With initial support from the Netherlands, the NDC Partnership will help countries leverage opportunities across the Water Nexus.

One in three U.K. drivers would consider buying non-annualised motor policy in the next year with pay-as-you-go product as most appealing

Retrieved on: 
Tuesday, February 28, 2023

LONDON, Feb. 28, 2023 /PRNewswire/ -- As nearly a third of U.K. drivers report that they are driving less to keep costs downi, new research from LexisNexis® Risk Solutions, the data, advanced analytics, and technology provider to the insurance market, indicates that one in three purchasers of motor insurance would be interested in buying a non-annualised policy (NAP) in the next 12 months, with pay-as-you-go policies having the most appealii. The findings are detailed in a new white paper, "Flexible, favourable, practical, profitable: Uncover consumer perceptions of non-annualised policies (NAPs) and their growing value in the motor insurance market." 

Key Points: 
  • The findings are detailed in a new white paper, " Flexible, favourable, practical, profitable: Uncover consumer perceptions of non-annualised policies (NAPs) and their growing value in the motor insurance market ."
  • In preparing the white paper, LexisNexis Risk Solutions undertook research with Consumer Intelligence to demonstrate the awareness, experiences and appetite for temporary, short-term and pay-as-you-go motor insurance cover.
  • It also highlights the need for greater industry collaboration to build more intelligence around non-annualised policies to support underwriting, pricing and reduce fraud.
  • "Our research has been driven by the insurance market's appetite for greater insights around a NAP data enrichment solution.